<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-106">
 <label>106</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Finn</surname>
    <given-names>JD</given-names>
   </name>
   <name>
    <surname>Nichols</surname>
    <given-names>TC</given-names>
   </name>
   <name>
    <surname>Svoronos</surname>
    <given-names>N</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapy.</article-title>
  <source>
   <italic>Blood.</italic>
  </source>
  <year>2012</year>;
  <volume>120</volume>(
  <issue>23</issue>):
  <fpage>4521</fpage>â€“
  <lpage>3</lpage>. 
  <pub-id pub-id-type="doi">10.1182/blood-2012-06-440123</pub-id>
  <!--<pub-id pub-id-type="pmcid">3512231</pub-id>-->
  <?supplied-pmid 22919027?>
  <pub-id pub-id-type="pmid">22919027</pub-id>
 </mixed-citation>
</ref>
